Ricevi le ultime notizie sulle azioni Twist Bioscience con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di TWST

Ultime notizie per

TWIST BIOSCIENCE CORP

Twist Bioscience

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience Corporation - Common Stock

Twist Bioscience Corp

Press Releases

Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors

Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution

Twist Bioscience Collaborates with Synthetic Design Lab

Twist Bioscience to Present at Baird 2025 Global Healthcare Conference

Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm

TWST

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celcuity

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Cogent Biosciences

Denali Therapeutics

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dyne Therapeutics

89bio

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Janux Therapeutics

Mesoblast Limited - American Depositary Shares

Mesoblast

MannKind

NuCana

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Arcus Biosciences

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Vericel

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics

Viridian Therapeutics, Inc. - Common Stock

Comments

Twist Bioscience Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO